[1] Schon MP.Animal models of psoriasis-what can we learn from them? JInvestDermatol,1999,112:405-410. [2] Nickoloff BJ,Wrone-Smith T,Bonish B,et al.Response of murine and normal human skin to injection of allogenic blood-derived psoriatic immunocytes,detection of T cells expressing receptors typically present on natural killer cells,including CD94,CD158 andCD161.ArchDermatol,1999,135:546-552. [3] Nicolas JF,Chamchick N,Thivolet J,et al.CD4 antibody treatment ofseverepaoriasis.Lancet,1991,338(8762):321. [4] Gottlieb SL,Gilleaudeau P,Johnson R,et al.Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2)suggests a primary immune,but not keratinocyte,pathogenicbasis.NatMed,1995,1:442-447. [5] Onrust SV,Wiseman LR.Basiliximab.Drugs,1999,57:207-213. |